5g21
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Leishmania major N-myristoyltransferase in complex with a quinoline inhibitor (compound 26).== | |
- | + | <StructureSection load='5g21' size='340' side='right' caption='[[5g21]], [[Resolution|resolution]] 1.50Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[5g21]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5G21 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5G21 FirstGlance]. <br> | |
- | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MYA:TETRADECANOYL-COA'>MYA</scene>, <scene name='pdbligand=YN4:ETHYL+4-[(2-CYANOETHYL)SULFANYL]-6-{[6-(PIPERAZIN-1-YL)'>YN4</scene></td></tr> | |
- | [[Category: | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5g1z|5g1z]], [[5g20|5g20]], [[5g22|5g22]]</td></tr> |
- | [[Category: | + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Glycylpeptide_N-tetradecanoyltransferase Glycylpeptide N-tetradecanoyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.3.1.97 2.3.1.97] </span></td></tr> |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5g21 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5g21 OCA], [http://pdbe.org/5g21 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5g21 RCSB], [http://www.ebi.ac.uk/pdbsum/5g21 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5g21 ProSAT]</span></td></tr> | |
- | [[Category: Brannigan, J | + | </table> |
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/Q4Q5S8_LEIMA Q4Q5S8_LEIMA]] Adds a myristoyl group to the N-terminal glycine residue of certain cellular proteins (By similarity). | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Glycylpeptide N-tetradecanoyltransferase]] | ||
+ | [[Category: Bell, A S]] | ||
+ | [[Category: Brannigan, J A]] | ||
[[Category: Goncalves, V]] | [[Category: Goncalves, V]] | ||
- | [[Category: Roberts, S.M]] | ||
- | [[Category: Tate, E.W]] | ||
[[Category: Laporte, A]] | [[Category: Laporte, A]] | ||
- | [[Category: | + | [[Category: Leatherbarrow, R J]] |
+ | [[Category: Roberts, S M]] | ||
+ | [[Category: Tate, E W]] | ||
+ | [[Category: Wilkinson, A J]] | ||
+ | [[Category: Drug design]] | ||
+ | [[Category: Inhibitor]] | ||
+ | [[Category: Malaria]] | ||
+ | [[Category: Myristoylation]] | ||
+ | [[Category: Quinoline]] | ||
+ | [[Category: Transferase]] |
Revision as of 17:34, 10 March 2017
Leishmania major N-myristoyltransferase in complex with a quinoline inhibitor (compound 26).
|